Los mejores oncohematólogos en Italia — TOP-5 médicos
acreditaciones:
El Dr. Andrés JM Ferreri es médico oncólogo con más de 300 artículos científicos publicados relacionados con el tratamiento de linfomas. Es Director Adjunto del Departamento de Hematología Oncológica y Director de la Unidad de Linfoma del Instituto Científico San Raffaele, así como Fundador de la Fundación Italiana de Linfoma. Es miembro de varias organizaciones médicas de prestigio y Profesor Contratado de Oncología en la Università Vita-Salute San Raffaele.
Mostrar más| Cita con el médico | precio a consultar |
| Trasplante de médula ósea | $166334 |
| Terapia de células T CAR | $124750.5 |
| Quimioterapia |
acreditaciones:
El profesor Fabio Ciceri es el Jefe de la Unidad de Hematología y Trasplante de Médula Ósea en el Hospital de Investigación San Raffaele y el Centro de Transfusión de Sangre. Tiene más de 180 artículos publicados y ha ocupado varios cargos médicos y docentes desde 1989. Es miembro de múltiples organizaciones relacionadas con la hematología y recibió un premio de reconocimiento al mérito en la Universidad de Ferrara. Es investigador principal en ensayos clínicos de terapia celular y génica para cánceres hematológicos, inmunodeficiencias y trastornos neuromusculares.
Mostrar más| Cita con el médico | precio a consultar |
| Trasplante de médula ósea | $166334 |
| Terapia de células T CAR | $124750.5 |
| Quimioterapia |
acreditaciones:
El Dr. Jacopo Peccatori es el Jefe del Departamento de Trasplante de Médula Ósea en el Instituto Científico San Raffaele y uno de los mejores médicos especialistas en linfoma. Ha estado en este puesto desde 2006 y ha escrito más de 70 estudios sobre trasplante alogénico de médula ósea, leucemia aguda y mieloma múltiple. Es licenciado en medicina general por la Universidad de Milán y tiene especialidades en medicina interna y hematología y es miembro de la Sociedad Europea de Trasplante de Sangre y Médula y del Grupo Italiano de Trasplante de Células Madre Hematopoyéticas y Terapias Celulares.
Mostrar más| Cita con el médico | precio a consultar |
| Trasplante de médula ósea | $166334 |
| Terapia de células T CAR | $124750.5 |
| Quimioterapia |
| Cita con el médico | precio a consultar |
| Trasplante de médula ósea | $166334 |
| Terapia de células T CAR | $124750.5 |
| Quimioterapia |
Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
- .Since 1997, he is the Director of the Department of Medical Oncology and Haematology, at Istituto Clinico Humanitas, Milan. Also, he is Member of the Ethics Committee of Istituto Clinico Humanitas and Director of Clinical Research in the same Institute since 2007.
- - Since 2008, he is Member of the Planning Committee, Ministry of Work and of Health and Social Politics, Rome, Italy.
- - Since October 2008, Professor Santoro is Counsellor of the Board of Directors of the Fondazione Humanitas for Research of Rozzano, Italy.
- - Since November 2008, he is Expert Member of the National Centre for the Prevention and Control of Disease, Ministry of Work and of Health and Social Politics (Rome, Italy).
- - Since February 2009, he is National Representative preparatory actions for the "European Partnership for Action against Cancer" Ministry of Work and of Health and Social Politics (Rome, Italy).
- - Since February 2009, Professor Santoro is member of National Italian Committee on the Research Network in Oncology, Ministry of Work and of Health and Social Politics (Rome, Italy).
- - Since May 2009, he is Coordinator of the Oesophageal-Stomach Cancer Group Coordinator of the Liver and Biliary Tree Cancer Group, Regional Oncology Commission – Lombardy Oncology Network.
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Mostrar másRevisado por el CEO de Bookimed